Scientists have identified hundreds of compounds inside the cannabis plant, revealing one of nature’s most complex biochemical systems. From rare cannabinoids to terpenes and biotechnology, researchers are uncovering a molecular universe shaping the future of medicine.
Cannabis seeds contain the genetic blueprint that determines plant structure, cannabinoid levels, terpene profiles, and resilience. As cultivation evolves globally, understanding genetics and choosing stable seed sources has become essential for growers seeking consistent, high-quality harvests.
Technion Israel Institute of Technology, Prof. Dedi Meiri is redefining cannabis science through molecular research. From cancer pathways to the endocannabinoid system, his lab maps how specific cannabinoid profiles interact with disease, bringing precision, data, and clarity to medical cannabis.
Before THC percentages and lab results, cannabis was chosen by scent. New research confirms aroma—not potency—drives enjoyment and effect. True Terpenes explores why smell has always been the soul of cannabis, blending culture, science, and sensory memory.
Israel’s first women-centered psychedelic conference, Marhivot Todaa, brought researchers, therapists, and cultural leaders together in Tel Aviv to examine gender gaps in research, ethics, sexuality, trauma, motherhood, and the future of psychedelic healing.
New UK research adds to growing evidence that medical cannabis may help people living with fibromyalgia manage chronic pain, anxiety, sleep issues, and overall quality of life. The large real-world study tracked patient outcomes over 18 months using cannabis-based treatments.
Governor Hochul has signed Senate Bill 2025-S3294A, delivering the most significant update to New York’s medical cannabis program since 2016. The law expands patient access, adds reciprocity, clarifies rights, and permits home cultivation for certified adults.
At Reykjavík’s Hemp4Future conference, scientists, advocates, and mothers turned data and lived experience into a new cannabis story—one rooted in courage, healing, and Iceland’s evolving path toward reform.
Four 20 Pharma CEO Torsten Greif is redefining medical cannabis in Germany — from EU-GMP supply chains and certified vapes to a historic soccer sponsorship that put plant medicine on the global stage.
Global Psychedelic Week 2025 unites 100 countries in a decentralized celebration of consciousness, equity, and community. From November 3–9, thousands will join virtual and local events shaping the future of psychedelics through inclusion, ethics, and global connection.
At The Butcher’s Daughter in NYC, Iconic Tonics—the functional drink brand from Snoop Dogg and Evan Eneman—unveiled a Kanna-based cocktail redefining nightlife. Discover how this plant-powered elixir blends wellness, connection, and the next wave of non-alcoholic culture.
If the U.S. cannabis industry shifts into a pharmaceutical model, what happens to the culture built on community, creativity, and flavor? We explore how pharma could reshape weed—and why preserving the experience matters more than ever.
Joey "Devil Doc Talk" Martinez has dedicated his life to advocating for veterans and mental health. With ADAX Entertainment and his "Devil Doc Talk Show," he ensures the voices of those who serve are heard. His Weedsday Playlist features hits by Gang Starr, KEM, and more.
PHCANN CEO Sasho Stefanoski shares how he scaled Europe’s largest medical supply chain, from a high-tech facility in Macedonia to partnerships with Tyson 2.0 and global markets like Germany, Poland, the UK, and Australia.
Chris Campagna turned a life-altering diagnosis into the launch of True Terpenes, redefining terpene science and cannabis flavor innovation. From rare disease to leading sensory teams and pushing beverage breakthroughs, his journey is as powerful as the plant itself.
